(May 30, 2019, 8:14 AM EDT) -- SHREVEPORT, La. — A company described by the federal government as the largest privately owned wholesale drug distributor in the United States has agreed to pay $22 million in civil penalties to resolve federal allegations that it violated the Controlled Substances Act by failing to report suspicious orders of the opioids hydrocodone and oxycodone, the parties announced May 24....